ArticlePharmaceuticals (Basel, Switzerland)2022

Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1

Costanza Ceni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.